BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 14647973)

  • 1. Beta-adrenoceptor polymorphisms.
    Leineweber K; Büscher R; Bruck H; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):1-22. PubMed ID: 14647973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic receptor polymorphism in human cardiovascular disease.
    Leineweber K
    Ann Med; 2004; 36 Suppl 1():64-9. PubMed ID: 15176426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
    Brodde OE
    Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.
    Leineweber K; Heusch G
    Br J Pharmacol; 2009 Sep; 158(1):61-9. PubMed ID: 19422376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of human beta-adrenergic receptor genes and their association with obesity.
    Liu ZQ; Mo W; Huang Q; Zhou HH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):359-67. PubMed ID: 17611309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.
    Ulucan C; Cetintas V; Tetik A; Eroglu Z; Kayikcioglu M; Can LH; Payzin S; Aydin M; Hasdemir C
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1053-8. PubMed ID: 18479335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can apical ballooning cardiomyopathy and anterior STEMI be differentiated based on β1 and β2-adrenergic receptors polymorphisms?
    Vriz O; Minisini R; Zito C; Boccato E; Fimiani F; Pirisi M; Facciolo C; Limongelli G; Bossone E; Calabrò P
    Int J Cardiol; 2015 Nov; 199():189-92. PubMed ID: 26197406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
    Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
    Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes.
    Leineweber K; Brodde OE
    Life Sci; 2004 Apr; 74(23):2803-14. PubMed ID: 15072081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenoceptor gene polymorphisms.
    Brodde OE; Leineweber K
    Pharmacogenet Genomics; 2005 May; 15(5):267-75. PubMed ID: 15864127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic beta1 receptor polymorphism (Ser49Gly) is associated with obesity in type II diabetic patients.
    Nonen S; Yamamoto I; Liu J; Maeda M; Motomura T; Igarashi T; Fujio Y; Azuma J
    Biol Pharm Bull; 2008 Feb; 31(2):295-8. PubMed ID: 18239290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic receptor gene polymorphisms and cardiovascular reactivity to stress in Black adolescents and young adults.
    Kelsey RM; Alpert BS; Dahmer MK; Krushkal J; Quasney MW
    Psychophysiology; 2010 Sep; 47(5):863-73. PubMed ID: 20374546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myocardial hypertrophy in patients with hypertensive disease: the role of genetic polymorphism of beta-adrenoreactive structures].
    Minushkina LO; Nikitin AG; Brazhnik VA; Brovkin AN; Nosikov VV; Zateĭshchikov DA
    Kardiologiia; 2010; 50(1):9-15. PubMed ID: 20144152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
    Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.
    Leineweber K; Frey UH; Tenderich G; Toliat MR; Zittermann A; Nürnberg P; Körfer R; Siffert W; Heusch G
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):357-65. PubMed ID: 20803192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of adrenergic receptor gene polymorphisms with adolescent obesity in Taiwan.
    Chou YC; Tsai CN; Lee YS; Pei JS
    Pediatr Int; 2012 Feb; 54(1):111-6. PubMed ID: 22115535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
    Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
    Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.